PortfoliosLab logo

iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA)

ETF · Currency in USD · Last updated May 21, 2022

IDNA is a passive ETF by iShares tracking the investment results of the NYSE FactSet Global Genomics and Immuno Biopharma Index. IDNA launched on Jun 11, 2019 and has a 0.47% expense ratio.

ETF Info

  • ISINUS46435U1925
  • CUSIP46435U192
  • IssueriShares
  • Inception DateJun 11, 2019
  • RegionNorth America (U.S.)
  • CategoryHealth & Biotech Equities
  • Expense Ratio0.47%
  • Index TrackedNYSE FactSet Global Genomics and Immuno Biopharma Index
  • Asset ClassEquity
  • Asset Class Size

    Multi-Cap
  • Asset Class Style

    Blend

Trading Data

  • Previous Close$29.02
  • Year Range$26.66 - $55.15
  • EMA (50)$31.58
  • EMA (200)$39.41
  • Average Volume$54.54K

IDNAShare Price Chart


Chart placeholderClick Calculate to get results

IDNAPerformance

The chart shows the growth of $10,000 invested in iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund on Jun 14, 2019 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $11,858 for a total return of roughly 18.58%. All prices are adjusted for splits and dividends.


IDNA (iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund)
Benchmark (^GSPC)

IDNAReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M-11.55%-12.57%
YTD-33.76%-18.14%
6M-38.76%-17.07%
1Y-35.34%-5.21%
5Y5.97%10.72%
10Y5.97%10.72%

IDNAMonthly Returns Heatmap


Chart placeholderClick Calculate to get results

IDNASharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund Sharpe ratio is -1.15. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


IDNA (iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund)
Benchmark (^GSPC)

IDNADividend History

iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund granted a 1.06% dividend yield in the last twelve months, as of May 21, 2022. The annual payout for that period amounted to $0.31 per share.


PeriodTTM202120202019
Dividend$0.31$0.31$0.12$0.24

Dividend yield

1.06%0.70%0.26%0.81%

IDNADrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


IDNA (iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund)
Benchmark (^GSPC)

IDNAWorst Drawdowns

The table below shows the maximum drawdowns of the iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund is 51.66%, recorded on May 11, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-51.66%Sep 3, 2021173May 11, 2022
-26.93%Mar 5, 20208Mar 16, 202023Apr 17, 202031
-22.23%Feb 9, 202119Mar 8, 2021107Aug 9, 2021126
-14.38%Jul 19, 201958Oct 9, 201930Nov 20, 201988
-13.58%Jul 21, 202035Sep 8, 202023Oct 9, 202058
-9.93%Oct 14, 202013Oct 30, 202019Nov 27, 202032
-9.34%Dec 26, 201925Jan 31, 202022Mar 4, 202047
-8.3%Dec 23, 20206Dec 31, 20209Jan 14, 202115
-7.52%Aug 10, 20218Aug 19, 202110Sep 2, 202118
-7.36%May 19, 202017Jun 11, 20207Jun 22, 202024

IDNAVolatility Chart

Current iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund volatility is 54.64%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


IDNA (iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund)
Benchmark (^GSPC)

Portfolios with iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund


Loading data...

More Tools for iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund